Pharmaceutical cognitive doping in students: ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Pharmaceutical cognitive doping in students: a chimeric way to get-a-head?
Auteur(s) :
Carton, Louise [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Cabe, Nicolas [Auteur]
CHU Caen
Menard, Olivier [Auteur]
Service de Psychiatrie [CHRU Lille]
Deheul, Sylvie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Caous, Anne-Sylvie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
DEVOS, DAVID [Auteur]
451074|||Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Cottencin, Olivier [Auteur]
415060|||Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Bordet, Regis [Auteur]
451074|||Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Cabe, Nicolas [Auteur]
CHU Caen
Menard, Olivier [Auteur]
Service de Psychiatrie [CHRU Lille]
Deheul, Sylvie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Caous, Anne-Sylvie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
DEVOS, DAVID [Auteur]
451074|||Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Cottencin, Olivier [Auteur]
415060|||Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Bordet, Regis [Auteur]
451074|||Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Titre de la revue :
Therapies
Nom court de la revue :
Therapie
Numéro :
73
Pagination :
331-339
Date de publication :
2018-03-06
ISSN :
0040-5957
Mot(s)-clé(s) en anglais :
Methylphenidate
Safety
Student
Psychostimulant
Cognitive doping
Equity
Safety
Student
Psychostimulant
Cognitive doping
Equity
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Sciences cognitives
Sciences cognitives
Résumé en anglais : [en]
For students, the pressing demands for memorization, top-level performance, and peer competition create an environment favorable for pharmaceutical cognitive doping behavior. We aimed to describe recent practices and the ...
Lire la suite >For students, the pressing demands for memorization, top-level performance, and peer competition create an environment favorable for pharmaceutical cognitive doping behavior. We aimed to describe recent practices and the benefit/risk ratio of such behavior and to discuss the issues at stake. The prevalence of pharmaceutical cognitive doping among students has been reported from 1.3% to 33% across studies, with variations depending on country and definition of pharmaceutical cognitive doping. The therapeutic classes most frequently cited as being diverted for doping purposes are psychostimulants and nootropics (methylphenidate, modafinil, piracetam), corticosteroids, sedative drugs and beta-blockers. Some illegal substances such as cannabis, amphetamines and cocaine are also consumed in order to boost mental function. Finally, over-the-counter products, such as caffeine-based tablets or energy drinks, or alcohol, are also widely used by students whose motivations involve enhanced performance, concentration, memory, and staying awake during the revision and exam period. However, the expected (often fantasized) effectiveness of these products does not correspond to the reality of a modest controversial impact on cognitive performance. There appears to be an emerging profile of the student more inclined to doping behavior. Cognitive doping thus raises the question of its regulation, opening a debate opposing, on one hand, individual freedom and supposed collective benefits and, on the other hand, health consequences, educational (in)equality, and the risk of tarnished academic success. Strengthening school and university medicine, through prevention campaigns and the identification of subjects at risk, is essential to limit the extent, risk, and damages associated with such practices.Lire moins >
Lire la suite >For students, the pressing demands for memorization, top-level performance, and peer competition create an environment favorable for pharmaceutical cognitive doping behavior. We aimed to describe recent practices and the benefit/risk ratio of such behavior and to discuss the issues at stake. The prevalence of pharmaceutical cognitive doping among students has been reported from 1.3% to 33% across studies, with variations depending on country and definition of pharmaceutical cognitive doping. The therapeutic classes most frequently cited as being diverted for doping purposes are psychostimulants and nootropics (methylphenidate, modafinil, piracetam), corticosteroids, sedative drugs and beta-blockers. Some illegal substances such as cannabis, amphetamines and cocaine are also consumed in order to boost mental function. Finally, over-the-counter products, such as caffeine-based tablets or energy drinks, or alcohol, are also widely used by students whose motivations involve enhanced performance, concentration, memory, and staying awake during the revision and exam period. However, the expected (often fantasized) effectiveness of these products does not correspond to the reality of a modest controversial impact on cognitive performance. There appears to be an emerging profile of the student more inclined to doping behavior. Cognitive doping thus raises the question of its regulation, opening a debate opposing, on one hand, individual freedom and supposed collective benefits and, on the other hand, health consequences, educational (in)equality, and the risk of tarnished academic success. Strengthening school and university medicine, through prevention campaigns and the identification of subjects at risk, is essential to limit the extent, risk, and damages associated with such practices.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Troubles cognitifs dégénératifs et vasculaires
Date de dépôt :
2019-11-27T13:34:05Z
2020-04-07T08:06:23Z
2023-06-05T11:41:30Z
2020-04-07T08:06:23Z
2023-06-05T11:41:30Z